- Recent Funding
- Investors
- Cambridge Enterprise Ventures
Cambridge Enterprise Ventures portfolio
Cambridge Enterprise Ventures has 6 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.
About this page
Its most recent investment on record is TRIMTECH Therapeutics's $14M Seed round in June 2026, alongside Eli Lilly, Cambridge Innovation Capital, Johnson & Johnson Innovation and 5 others. By category, its portfolio leans toward Health and bio (3) and Legal and compliance (1). It has co-invested with Cambridge Innovation Capital, Business Growth Fund and F-Prime Capital, most often Cambridge Innovation Capital (3 rounds).
What Cambridge Enterprise Ventures invests in
- Health and bio · 3 · 50%
- Legal and compliance · 1 · 17%
- Cybersecurity · 1 · 17%
- Robotics and hardware · 1 · 17%
- Manufacturing and industrial · 1 · 17%
- Insurance · 1 · 17%
- Climate and energy · 1 · 17%
- Data and analytics · 1 · 17%
Cambridge Enterprise Ventures recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Seed · $14M | Eli Lilly, Cambridge Innovation Capital, Johnson & Johnson Innovation (lead) +5 | ||
| Series A · $86.45M | Cambridge Innovation Capital, Qiming Venture Partners, SR One +2 | ||
| Series A · $91M | Digitalis Ventures, Cambridge Innovation Capital, Tencent +4 |
How Cambridge Enterprise Ventures invests
Cambridge Enterprise Ventures portfolio companies
TTRIMTECH Therapeutics$14MSeed · Jun 2026
IImmutrin$86.45MSeries A · Mar 2026
TT-Therapeutics$91MSeries A · Nov 2025
HHacktron AIbacker
SSparxellbacker
PPinepeakbacker
| Company | Round with Cambridge Enterprise Ventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Seed · $14M | $45M | Jun 23, 2026 Seed |
Health and bio |
Series A · $86.45M | $86.45M | Mar 26, 2026 Series A |
Health and bio |
Series A · $91M | $283M | Nov 5, 2026 Series B+ |
Legal and compliance |
backer | undisclosed | May 13, 2026 Seed |
Robotics and hardware |
backer | $8.2M | Feb 2, 2026 Series A |
Insurance |
backer | undisclosed | Apr 11, 2025 Pre-seed |
Most frequent co-investors
CCambridge Innovation Capital3 shared rounds · last Jun 23, 2026
BBusiness Growth Fund2 shared rounds · last Jun 23, 2026
FF-Prime Capital2 shared rounds · last Mar 26, 2026
EEli Lilly1 shared round · last Jun 23, 2026
MM Ventures1 shared round · last Jun 23, 2026
MMP Healthcare Venture Management1 shared round · last Jun 23, 2026
JJohnson & Johnson Innovation1 shared round · last Jun 23, 2026
DDementia Discovery Fund1 shared round · last Jun 23, 2026
PPfizer Venture Investments1 shared round · last Jun 23, 2026
SSR One1 shared round · last Mar 26, 2026
QQiming Venture Partners1 shared round · last Mar 26, 2026
FFrazier Life Sciences1 shared round · last Mar 26, 2026
Similar investors
AAdage Capital Management6 companies · 4 deals in 12 mo
HHealthier Capital6 companies · 4 deals in 12 mo
SSymBiosis6 companies · 4 deals in 12 mo
UUC Investments6 companies · 4 deals in 12 moAAbingworth6 companies · 3 deals in 12 mo
HHBM Healthcare Investments6 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 3 rounds on Recent Funding that name Cambridge Enterprise Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Cambridge Enterprise Ventures, which is a subset of its real portfolio. API: /api/v1/investors/cambridge-enterprise-ventures (get a free API key). More: the most active VC firms and new venture capital funds.